Molecular Life Sciences CMLS 81, 401
Life 14:559
Patients who achieve significant weight loss through GLP-1 treatment may benefit from surgical body contouring to address excess skin and residual fat deposits
Certain patients experience decreased appetite, improved weight control, and increased mobility with GLP-1s
Do not use GLP-1s if you: Have a personal or family history of certain types of thyroid cancer (e.g., medullary thyroid carcinoma) or multiple endocrine neoplasia type 2 Have had pancreatitis or gallbladder disease unless cleared by your doctor Are pregnant, planning to become pregnant, or breastfeeding Have severe gastrointestinal disease (consult your healthcare provider) Common side effects may include: Nausea, especially during the first few weeks Constipation or diarrhea Fatigue or low energy Mild stomach cramping Temporary decrease in appetite To reduce side effects, your provider will typically start with a low dose and increase gradually
When semaglutide slows gastric transit, the NSAID remains active in your stomach longer, amplifying its irritant effects